These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3745920

  • 1. Mast cell "disappearance" in chronic murine graft-vs-host disease (GVHD)-ultrastructural demonstration of "phantom mast cells".
    Claman HN, Choi KL, Sujansky W, Vatter AE.
    J Immunol; 1986 Sep 15; 137(6):2009-13. PubMed ID: 3745920
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous mast cell depletion and recovery in murine graft-vs-host disease.
    Choi KL, Giorno R, Claman HN.
    J Immunol; 1987 Jun 15; 138(12):4093-101. PubMed ID: 2953799
    [Abstract] [Full Text] [Related]

  • 3. Chronic graft-versus-host disease as a model for scleroderma. II. Mast cell depletion with deposition of immunoglobulins in the skin and fibrosis.
    Claman HN, Jaffee BD, Huff JC, Clark RA.
    Cell Immunol; 1985 Aug 15; 94(1):73-84. PubMed ID: 4016962
    [Abstract] [Full Text] [Related]

  • 4. Mast cell depletion in murine chronic graft-versus-host disease.
    Claman HN.
    J Invest Dermatol; 1985 Apr 15; 84(4):246-8. PubMed ID: 3981034
    [Abstract] [Full Text] [Related]

  • 5. Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease.
    Levi-Schaffer F, Segal V, Barak V, Rubinchik E, Nagler A.
    Exp Hematol; 1997 Mar 15; 25(3):238-45. PubMed ID: 9091300
    [Abstract] [Full Text] [Related]

  • 6. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease.
    Levi-Schaffer F, Goldenhersh MA, Segal V, Nagler A.
    Bone Marrow Transplant; 1997 Apr 15; 19(8):823-8. PubMed ID: 9134176
    [Abstract] [Full Text] [Related]

  • 7. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA.
    J Immunol; 1993 Jan 01; 150(1):265-77. PubMed ID: 8417127
    [Abstract] [Full Text] [Related]

  • 8. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM, Statton D, Jones SC, Berger MA, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2001 Jan 01; 7(1):2-13. PubMed ID: 11215694
    [Abstract] [Full Text] [Related]

  • 9. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.
    Transplantation; 2007 Jul 27; 84(2):214-22. PubMed ID: 17667813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen-binding factor.
    Kops SK, Van Loveren H, Rosenstein RW, Ptak W, Askenase PW.
    Lab Invest; 1984 Apr 27; 50(4):421-34. PubMed ID: 6608629
    [Abstract] [Full Text] [Related]

  • 13. Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor.
    Florenzano F, Bentivoglio M.
    J Comp Neurol; 2000 Sep 04; 424(4):651-69. PubMed ID: 10931487
    [Abstract] [Full Text] [Related]

  • 14. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 15. Depressed IL-1 production by chronic GVHD dermal fibroblasts.
    Mekori YA, Huleihel M, Baram D, Apte RN.
    Eur Cytokine Netw; 1990 Apr 15; 1(2):77-83. PubMed ID: 2102813
    [Abstract] [Full Text] [Related]

  • 16. Hepatic homing of mononuclear inflammatory cells isolated during murine chronic graft-vs-host disease.
    Howell CD, Yoder T, Claman HN, Vierling JM.
    J Immunol; 1989 Jul 15; 143(2):476-83. PubMed ID: 2472440
    [Abstract] [Full Text] [Related]

  • 17. Preventive effect of ultraviolet radiation on murine chronic sclerodermatous graft-versus-host disease.
    Mermet I, Kleinclauss F, Marandin A, Guérrini JS, Angonin R, Tiberghien P, Saas P, Aubin F.
    Transplantation; 2007 Dec 27; 84(12):1696-700. PubMed ID: 18165783
    [Abstract] [Full Text] [Related]

  • 18. A two-phase pathogenesis of graft-versus-host disease in mice.
    van Leeuwen L, Guiffre A, Atkinson K, Rainer SP, Sewell WA.
    Bone Marrow Transplant; 2002 Jan 27; 29(2):151-8. PubMed ID: 11850710
    [Abstract] [Full Text] [Related]

  • 19. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST, Radaszkiewicz T, Gleichmann E.
    J Immunol; 1984 Apr 27; 132(4):1669-78. PubMed ID: 6230390
    [Abstract] [Full Text] [Related]

  • 20. Ultrastructural features of mast cells in picryl chloride (PCL)-induced contact dermatitis in IQI/Jic mice.
    Jung JY, Yasoshima A, Saegusa J, Nakayama H, Doi K.
    Exp Toxicol Pathol; 2003 Mar 27; 54(4):265-71. PubMed ID: 12710708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.